Matthew Gline
CEO at Roivant Sciences · 13 reported transactions in 1 company · latest trade Dec 15, 2025
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +89.2%, S&P 500 +0.6% over the same days.
Their trades
Sold | Dec 15, 2025 | Dec 15, 2025 close $21.90 → Oct 29, 2026 close $37.52. S&P 500 +13.4% over the same days. | ||
Sold | Dec 15, 2025 | Dec 15, 2025 close $21.90 → Oct 29, 2026 close $37.52. S&P 500 +13.4% over the same days. |
SoldRoivant Sciences
$20.46M
Dec 15, 2025 close $21.90 → Oct 29, 2026 close $37.52. S&P 500 +13.4% over the same days.
SoldRoivant Sciences
$12.27M
Dec 15, 2025 close $21.90 → Oct 29, 2026 close $37.52. S&P 500 +13.4% over the same days.